Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9355959 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL9011314 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL1453792 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL1454054 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL11264853 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL1454393 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL1455140 | 0.98 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL809566 | 0.93 | ALDH1A1 (0.58) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL38948 | 0.93 | ALDH1A1 (0.58) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL11353374 | 0.93 | ALDH1A1 (0.58) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115087644-A | Additive mixture for rheology modification of polymers | 巴斯夫欧洲公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-110678510-B | Nucleating agents, methods of making the same and related polymer compositions | 巴斯夫欧洲公司 | 2022-03-29 | — | — | CN | disclosed |
| US-11192865-B2 | Benzosulfonyl compounds | VIVACE THERAPEUTICS, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| CN-113637514-A | Composition and method of forming the same | 巴斯夫欧洲公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-113597416-A | Shaped synthetic polymer article | 巴斯夫欧洲公司 | 2021-11-02 | — | — | CN | disclosed |
| US-20200354325-A1 | BENZOSULFONYL COMPOUNDS | VIVACE THERAPEUTICS, INC. | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192865-B2 | Benzosulfonyl compounds | YAP1, TEAD2, TEAD1 | ALDH1A1 2161/4885CYP3A4 3226/4885ALOX15 3108/4885 |
| US-20200354325-A1 | BENZOSULFONYL COMPOUNDS | YAP1, TEAD2, TEAD1 | ALDH1A1 2161/4885CYP3A4 3226/4885ALOX15 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.